A research group led by Gian Gaetano Tartaglia, Principal Investigator at the Italian Institute of Technology (IIT), ...

SNUG01 is a first-in-class targeted gene therapy that’s designed to increase the levels of TRIM72, a protein with ...

Herbicide-resistant weeds challenge producers and agrochemical companies with a vexing issue that some refer to as a ‘wicked ...

Accumulation of a protein called TDP-43 is a key feature of ALS and frontotemporal dementia. In a newly published study, researchers report ‘seeding’ this accumulation through fragments of the culprit ...

Accumulation of a protein called TDP-43 is a key feature of ALS and frontotemporal dementia. In a newly published study, ...

Researchers have developed a laboratory model that mimics the pathological aggregation of TDP-43, a key protein in ALS and ...

Neurosense reports Canadian regulators want a meeting that could lead to PrimeC's conditional approval there, and further ...

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the publication of new preclinical research in Free Radical Biology and Medicine, highlighting the role of edaravone in mitigating TDP-43 ...

Manuscript Summary Submission Deadline 30 May 2025 | Manuscript Submission Deadline 29 June 2025 | Manuscript Extension Submission Deadline 30 July 2025 ...

UCLA Health researchers say study findings uncover Huntington's disease mechanisms and pave new ways to develop treatments.